Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan

SUMMARY: Model-based economic evaluation was performed to assess the cost-effectiveness of zoledronic acid. Although zoledronic acid was dominated by alendronate, the incremental quality-adjusted life year (QALY) was quite small in extent. Considering the advantage of once-yearly injection of zoledr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriwaki, K., Mouri, M., Hagino, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486933/
https://www.ncbi.nlm.nih.gov/pubmed/28265718
http://dx.doi.org/10.1007/s00198-017-3973-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486933/
https://www.ncbi.nlm.nih.gov/pubmed/28265718
http://dx.doi.org/10.1007/s00198-017-3973-8

Ejemplares similares